AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients

Experimental fibroblast growth factor 21 (FGF21) analogs can improve lipid profiles in patients with metabolic diseases. However, their effects on markers of insulin sensitivity appear to be minimal, potentially because of insufficient exposure. Systemic drug levels vary from sub-pharmacological to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufman, Allegra, Abuqayyas, Lubna, Denney, William S., Tillman, Erik J., Rolph, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659583/
https://www.ncbi.nlm.nih.gov/pubmed/33205064
http://dx.doi.org/10.1016/j.xcrm.2020.100057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659583/
https://www.ncbi.nlm.nih.gov/pubmed/33205064
http://dx.doi.org/10.1016/j.xcrm.2020.100057

Ejemplares similares